TrademarkDir
TELIX PHARMACEUTICALS
LIVE

Serial Number

79257540

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Mar 14, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TELIX PHARMACEUTICALS Trademark

Serial Number: 79257540 • Registration: 6908866

TELIX PHARMACEUTICALS is a trademark filed by Telix Pharmaceuticals Limited on March 14, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

March 14, 2019

Registration Date

November 29, 2022

Published for Opposition

September 13, 2022

Goods & Services

Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing cancer; drug delivery systems for the treatment, prevention, or diagnosis of cancer, namely, applicators for pharmaceutical preparations sold without medication for use in the treatment, prevention, or diagnosis of cancer

Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products for use in the treatment, prevention, or diagnosis of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 19, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 16, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 16, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 29, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 29, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Sep 11, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 24, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 24, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2022 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2022 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2022 CNEA
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Aug 9, 2022 LIME
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Aug 9, 2022 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Oct 3, 2021 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 23, 2021 ERFR
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Aug 15, 2021 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Jul 31, 2021 LIMG
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 12, 2021 GNFN
FINAL REFUSAL E-MAILED
Mar 12, 2021 GNFR
FINAL REFUSAL WRITTEN
Mar 12, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2021 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 17, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 30, 2020 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 17, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 12, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 12, 2020 CNRT
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2020 FINT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2019 TROA
REFUSAL PROCESSED BY IB
Jul 12, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 14, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 14, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 30, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 29, 2019 CNRT
ASSIGNED TO EXAMINER
May 23, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
May 14, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 8, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 25, 2019 SDRC

Related Trademarks

More from this Owner

LUTEON

LUTEON

PTHER-PAN

PTHER-PAN

PTHER-PAN

PTHER-PAN

BIPASS

BIPASS

BIPASS

BIPASS

UROONCRX ONSITE PRECISION RADIOPHARMACY logo

UROONCRX ONSITE PRECISION RADIOPHARMACY